Search
+
    SEARCHED FOR:

    REDNEX

    Under the scanner, yet generic cough syrups hit shelves

    Worry is spreading regarding the multitude of cough syrup brands circulating in India, with alarming revelations of toxic diethylene glycol detected in some, resulting in heartbreaking instances of child mortality. This situation sheds light on the questionable efficacy of regulatory measures, as many small-scale producers evade scrutiny.

    WHO issues warning against three ‘substandard’ cough syrups in India

    The World Health Organisation has issued a global alert for three Indian cough syrups. These syrups were found to be substandard and contained a toxic substance. Reports indicate child deaths in India linked to these products. Regulatory authorities worldwide are urged to be vigilant. The affected syrups have been recalled and production halted.

    Cough syrup advisory: Check names of three banned toxic syrups and five harmful ingredients parents should watch out for

    India has declared three cough syrups toxic following the deaths of at least 17 children. Investigations revealed high levels of diethylene glycol, a toxic substance, in Coldrif, Respifresh TR, and Relife. Authorities have banned Coldrif, arrested its manufacturer, and ordered recalls for the other two syrups.

    India declares three cough syrups toxic after child deaths

    India has declared three cough syrups toxic. Seventeen children have died in the past month. All deaths are linked to Coldrif. Regulators also advise avoiding Respifresh TR and ReLife. None of the syrups were exported. The World Health Organization warned of risks through unregulated channels. Coldrif contained high levels of diethylene glycol. The owner of Sresan Pharmaceutical Manufacturer was arrested.

    India flags testing lapses at pharma firms after cough syrups deaths

    India's drug regulator revealed serious lapses in pharmaceutical firms failing to test medicinal ingredients, following the deaths of 17 children linked to toxic cough syrups. Inspections found companies not testing raw materials or finished products, despite stricter rules implemented after previous overseas fatalities. Action is being taken against manufacturers found to be non-compliant.

    All medicines of Sresan Pharmaceuticals banned from sale in Kerala

    Health Minister Veena George announced that all medicines manufactured by Sresan Pharmaceuticals, a company based in Kanchipuram, Tamil Nadu, have been banned from distribution and sale in Kerala. The move follows action taken by the Tamil Nadu Drugs Controller to cancel the company's manufacturing license.

    • Two Gujarat cos under lens for DEG-laden cough syrup; FDA issues alert

      Gujarat's Food and Drugs Administration has issued a public alert, prohibiting the sale of specific cough syrup batches from Rednex Pharmaceuticals and Shape Pharmaceutical. These formulations were found to contain Diethylene Glycol (DEG) impurity above permissible limits, rendering them adulterated and not of standard quality.

      Load More
    The Economic Times
    BACK TO TOP